ATE242005T1 - P277 peptidanaloge, pharmazeutische zusammenstellung davon zur behandlung und diagnose von diabetes - Google Patents

P277 peptidanaloge, pharmazeutische zusammenstellung davon zur behandlung und diagnose von diabetes

Info

Publication number: ATE242005T1
Authority: AT; Austria
Prior art keywords: diabetes; diagnosis; treatment; pharmaceutical composition; peptide analogues
Prior art date: 1994-12-21

Application number

AT95944502T

Other languages

English (en)

Inventor

Irun R Cohen

Dana Elias

Matityahu Fridkin

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-21

Filing date

1995-12-20

Publication date

2003-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE242005(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-12-21 Priority claimed from IL11209494A external-priority patent/IL112094A0/xx

1995-07-05 Priority claimed from IL11446095A external-priority patent/IL114460A0/xx

1995-12-20 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

2003-06-15 Application granted granted Critical

2003-06-15 Publication of ATE242005T1 publication Critical patent/ATE242005T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Diabetes (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Veterinary Medicine (AREA)
Rehabilitation Therapy (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AT95944502T 1994-12-21 1995-12-20 P277 peptidanaloge, pharmazeutische zusammenstellung davon zur behandlung und diagnose von diabetes ATE242005T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IL11209494A IL112094A0 (en)	1994-12-21	1994-12-21	Novel peptides and pharmaceutical compositions comprising them
IL11446095A IL114460A0 (en)	1995-07-05	1995-07-05	Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
PCT/US1995/016596 WO1996019236A1 (en)	1994-12-21	1995-12-20	PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES

Publications (1)

Publication Number	Publication Date
ATE242005T1 true ATE242005T1 (de)	2003-06-15

Family

ID=26322965

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95944502T ATE242005T1 (de)	1994-12-21	1995-12-20	P277 peptidanaloge, pharmazeutische zusammenstellung davon zur behandlung und diagnose von diabetes

Country Status (31)

Country	Link
EP (1)	EP0820303B1 (de)
JP (2)	JP3420245B2 (de)
KR (1)	KR100400480B1 (de)
CN (1)	CN1233417C (de)
AR (1)	AR002949A1 (de)
AT (1)	ATE242005T1 (de)
AU (1)	AU707835B2 (de)
BR (1)	BR9510102A (de)
CA (1)	CA2208274C (de)
CZ (1)	CZ293784B6 (de)
DE (2)	DE69531004T2 (de)
DK (1)	DK0820303T3 (de)
ES (1)	ES2201137T3 (de)
FI (1)	FI118373B (de)
HR (1)	HRP950612B1 (de)
HU (1)	HU224160B1 (de)
IL (1)	IL116499A0 (de)
IS (1)	IS1966B (de)
MX (1)	MX9704738A (de)
NO (1)	NO317350B1 (de)
NZ (1)	NZ301440A (de)
PL (1)	PL184145B1 (de)
PT (1)	PT820303E (de)
RO (1)	RO116777B1 (de)
RS (1)	RS49517B (de)
SI (1)	SI0820303T1 (de)
TR (1)	TR199501630A2 (de)
TW (1)	TW496872B (de)
UA (1)	UA42040C2 (de)
UY (1)	UY24130A1 (de)
WO (1)	WO1996019236A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6488933B2 (en)	1995-07-05	2002-12-03	Yeda Research And Development Co. Ltd.	Preparations for the treatment of T cell mediated diseases
US6451541B1 (en) *	1996-05-14	2002-09-17	Ernst-Ludwig Winnacker	Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc
WO2002016549A2 (en) *	2000-08-25	2002-02-28	Yeda Research And Development Co. Ltd.	METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE
IL140233A0 (en) *	2000-12-11	2002-02-10	Peptor Ltd	Backbone cyclized analogs of heat shock proteins
EP1575479A4 (de)	2002-01-31	2006-10-25	Develogen Israel Ltd	Hsp-peptide und analoga zur modulation von immunantworten über antigen präsentierende zellen
CA2595520A1 (en) *	2004-01-28	2005-08-11	Develogen Israel Ltd.	Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) *	2004-09-10	2006-03-30	Sanofi-Aventis Deutschland Gmbh	Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
CN100352502C (zh) *	2004-12-29	2007-12-05	中国药科大学	能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
EP1835933A4 (de) *	2005-01-04	2015-01-07	Yeda Res & Dev	Hsp60, hsp60-peptide und t-zellen-impfstoffe zur immunmodulation
JP2008531730A (ja) *	2005-03-04	2008-08-14	キュアーディーエム、インク．	Ｉ型真性糖尿病及び他の症状を治療するための方法及び薬学的組成物
US7393919B2 (en)	2005-05-25	2008-07-01	Cure Dm, Inc.	Peptides, derivatives and analogs thereof, and methods of using same
JP4283812B2 (ja) *	2006-01-06	2009-06-24	財団法人工業技術研究院	重症筋無力症の診断方法およびそのキット
WO2008064306A2 (en)	2006-11-22	2008-05-29	Curedm, Inc.	Methods and compositions relating to islet cell neogenesis
NZ599756A (en)	2007-08-30	2013-09-27	Curedm Group Holdings Llc	Compositions and methods of using proislet peptides and analogs thereof
CU23701A1 (es) *	2008-12-29	2011-09-21	Ct Ingenieria Genetica Biotech	Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
JP2015508812A (ja)	2012-03-01	2015-03-23	イエダリサーチアンドディベロプメントカンパニーリミテッド	非自己免疫性糖尿病を抑制および処置するためのｈｓｐ６０由来ペプチドおよびペプチド類似体
EP2819689A1 (de)	2012-03-01	2015-01-07	Yeda Research and Development Co. Ltd.	Regenerierung von beta-inselzellen durch hsp60-derivierte peptide
CN104418948B (zh) *	2013-09-10	2019-08-16	深圳翰宇药业股份有限公司	一种制备多肽药物的方法
CN104650209B (zh) *	2013-11-19	2018-04-06	深圳翰宇药业股份有限公司	多肽药物DiaPep277 的合成方法
CN104650244B (zh) *	2015-01-21	2017-12-08	中国药科大学	一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5114844A (en) *	1989-03-14	1992-05-19	Yeda Research And Development Co., Ltd.	Diagnosis and treatment of insulin dependent diabetes mellitus

1995
- 1995-12-20 DE DE69531004T patent/DE69531004T2/de not_active Expired - Lifetime
- 1995-12-20 NZ NZ301440A patent/NZ301440A/xx not_active IP Right Cessation
- 1995-12-20 MX MX9704738A patent/MX9704738A/es unknown
- 1995-12-20 PT PT95944502T patent/PT820303E/pt unknown
- 1995-12-20 RO RO97-01173A patent/RO116777B1/ro unknown
- 1995-12-20 SI SI9530664T patent/SI0820303T1/xx unknown
- 1995-12-20 UA UA97063404A patent/UA42040C2/uk unknown
- 1995-12-20 JP JP51996596A patent/JP3420245B2/ja not_active Expired - Fee Related
- 1995-12-20 HU HU9901771A patent/HU224160B1/hu active IP Right Grant
- 1995-12-20 EP EP95944502A patent/EP0820303B1/de not_active Expired - Lifetime
- 1995-12-20 DK DK95944502T patent/DK0820303T3/da active
- 1995-12-20 CN CNB95197680XA patent/CN1233417C/zh not_active Expired - Lifetime
- 1995-12-20 PL PL95321091A patent/PL184145B1/pl unknown
- 1995-12-20 ES ES95944502T patent/ES2201137T3/es not_active Expired - Lifetime
- 1995-12-20 AU AU46866/96A patent/AU707835B2/en not_active Expired
- 1995-12-20 AT AT95944502T patent/ATE242005T1/de active
- 1995-12-20 DE DE0820303T patent/DE820303T1/de active Pending
- 1995-12-20 BR BR9510102A patent/BR9510102A/pt active IP Right Grant
- 1995-12-20 WO PCT/US1995/016596 patent/WO1996019236A1/en active Search and Examination
- 1995-12-20 KR KR1019970704281A patent/KR100400480B1/ko not_active IP Right Cessation
- 1995-12-20 CZ CZ19971908A patent/CZ293784B6/cs not_active IP Right Cessation
- 1995-12-20 CA CA002208274A patent/CA2208274C/en not_active Expired - Lifetime
- 1995-12-21 HR HR950612A patent/HRP950612B1/xx not_active IP Right Cessation
- 1995-12-21 IL IL11649995A patent/IL116499A0/xx not_active IP Right Cessation
- 1995-12-21 RS YU78795A patent/RS49517B/sr unknown
- 1995-12-21 AR AR10071295A patent/AR002949A1/es unknown
- 1995-12-21 TR TR95/01630A patent/TR199501630A2/xx unknown
- 1995-12-21 UY UY24130A patent/UY24130A1/es unknown
1996
- 1996-01-05 TW TW085100088A patent/TW496872B/zh not_active IP Right Cessation
1997
- 1997-06-19 IS IS4510A patent/IS1966B/is unknown
- 1997-06-19 FI FI972669A patent/FI118373B/fi not_active IP Right Cessation
- 1997-06-19 NO NO19972849A patent/NO317350B1/no not_active IP Right Cessation
2003
- 2003-01-30 JP JP2003022033A patent/JP3554319B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
YU78795A (sh)	1998-05-15
EP0820303A4 (de)	1998-03-11
NO972849L (no)	1997-08-13
SI0820303T1 (en)	2003-10-31
HRP950612A2 (en)	1997-10-31
FI118373B (fi)	2007-10-31
DE820303T1 (de)	1999-05-20
EP0820303A1 (de)	1998-01-28
ES2201137T3 (es)	2004-03-16
RO116777B1 (ro)	2001-06-29
CA2208274A1 (en)	1996-06-27
TW496872B (en)	2002-08-01
UA42040C2 (uk)	2001-10-15
JP2004026797A (ja)	2004-01-29
MX9704738A (es)	1997-10-31
PL184145B1 (pl)	2002-09-30
AR002949A1 (es)	1998-05-27
CN1233417C (zh)	2005-12-28
PL321091A1 (en)	1997-11-24
NO972849D0 (no)	1997-06-19
FI972669A0 (fi)	1997-06-19
AU4686696A (en)	1996-07-10
IL116499A0 (en)	1996-03-31
NZ301440A (en)	2000-01-28
CN1175214A (zh)	1998-03-04
DE69531004T2 (de)	2004-02-05
WO1996019236A1 (en)	1996-06-27
FI972669A (fi)	1997-08-15
PT820303E (pt)	2003-10-31
BR9510102A (pt)	1997-11-25
JPH10511649A (ja)	1998-11-10
IS4510A (is)	1997-06-19
TR199501630A2 (tr)	1996-07-21
DE69531004D1 (de)	2003-07-10
RS49517B (sr)	2006-10-27
DK0820303T3 (da)	2003-10-06
CZ293784B6 (cs)	2004-07-14
IS1966B (is)	2004-12-15
NO317350B1 (no)	2004-10-18
JP3420245B2 (ja)	2003-06-23
CZ190897A3 (en)	1997-11-12
UY24130A1 (es)	1996-06-11
JP3554319B2 (ja)	2004-08-18
EP0820303B1 (de)	2003-06-04
HRP950612B1 (en)	2003-12-31
HU224160B1 (hu)	2005-06-28
CA2208274C (en)	2005-12-06
KR100400480B1 (ko)	2003-12-31
AU707835B2 (en)	1999-07-22
HUT78092A (hu)	1999-09-28

Publication	Publication Date	Title
ATE242005T1 (de)	2003-06-15	P277 peptidanaloge, pharmazeutische zusammenstellung davon zur behandlung und diagnose von diabetes
DE69929996D1 (de)	2006-04-27	Pharmazeutisches mittel zur behandlung von diabetes
DE69334246D1 (de)	2008-12-24	Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
ATE256463T1 (de)	2004-01-15	Pharmazeutische zubereitung zur verwendung in der behandlung von diabetes
DE69725339D1 (de)	2003-11-06	Vorrichtung zur diagnose und behandlung von arrhythmien
DE69942614D1 (de)	2010-09-02	Vorrichtung zur diagnose und therapie von elektrophysiologischen krankheiten
DE60043305D1 (de)	2009-12-24	Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ATE204754T1 (de)	2001-09-15	Pharmazeutische zusammensetzung von metformin und fibrat, und ihre verwendung zur behandlung von hyperglykämie
DE60030109D1 (de)	2006-09-28	(-)(3-trihalomethylphenoxy) (4-halophenyl) zur behandlung von insulinresistenz und typ ii diabetes
DE58908452D1 (de)	1994-11-03	Medizinisches Gerät zur Diagnose und/oder Therapie.
DE69420229D1 (de)	1999-09-30	Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69829217D1 (de)	2005-04-07	Vorrichtung zur therapeutischen behandlung von blutgefässen
DE69939075D1 (de)	2008-08-21	Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
FI971427A (fi)	1997-05-26	Peptidit ja niitä sisältävät farmaseuttiset koostumukset
DE68909933D1 (de)	1993-11-18	Für zellen eindringbares medizinisches material und kunsthaut.
RU94002476A (ru)	1995-10-27	Лекарственное средство
ID27023A (id)	2001-02-22	Turunan imidazola bersubstitusi bifenilsulfonil, proses penyiapannya, penggunaannya sebagai obat atau zat diagnosa dan obat yang mengandungnya
ZA9510828B (en)	1996-07-29	Peptide p277 analogs and phamarceutical compositions comprising them for treatment or diagnosis of diabetes
DE68914886D1 (de)	1994-06-01	Mittel zur Behandlung von Raynaud's Krankheit.
IL114460A0 (en)	1995-11-27	Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
ATE59776T1 (de)	1991-01-15	Pharmazeutische zusammensetzung und behandlung.
RU94022862A (ru)	1996-03-27	Способ экспресс-диагностики аденомы щитовидной железы
TH54857A3 (th)	2003-01-30	องค์ประกอบตัวใหม่และการใช้
RU2001123675A (ru)	2003-05-10	Средство бальзам "ГРААЛЬ" для лечения сердечно-сосудистой системы и заболеваний крови человека
DE59609353D1 (de)	2002-07-25	Mittel zur subkutanen Verabreichung von Protein C

Legal Events

Date	Code	Title	Description
2004-03-15	UEP	Publication of translation of european patent specification	Ref document number: 0820303 Country of ref document: EP

Date

Code

Title

Description

2004-03-15

UEP

Publication of translation of european patent specification

Ref document number: 0820303

Country of ref document: EP